C Thallinger1, G Prager, H Ringl, C Zielinski. 1. Klinische Abteilung für Onkologie, Comprehensive Cancer Center, Universitätsklinik für Innere Medizin I, AKH Wien, Medizinische Universität Wien, Währingergürtel 18-20, 1090, Wien, Österreich, Christiane.Thallinger@meduniwien.ac.at.
Abstract
BACKGROUND: The clearance of non-irradiated tumors after localized radiation therapy is known as the abscopal effect. CASE REPORT: In the present case report we initiated a combined therapeutic approach based on sequential administration of ipilimumab plus temozolomide in combination with radiotherapy. The treatment regime was well tolerated and resulted in unusually long disease stabilization and in a complete response of brain and kidney metastases. Thus, it is speculated that the clinical response was the result of an abscopal effect. CONCLUSION: The present case report highlights the possible clinical benefit of the abscopal effect in the treatment of malignant melanoma.
BACKGROUND: The clearance of non-irradiated tumors after localized radiation therapy is known as the abscopal effect. CASE REPORT: In the present case report we initiated a combined therapeutic approach based on sequential administration of ipilimumab plus temozolomide in combination with radiotherapy. The treatment regime was well tolerated and resulted in unusually long disease stabilization and in a complete response of brain and kidney metastases. Thus, it is speculated that the clinical response was the result of an abscopal effect. CONCLUSION: The present case report highlights the possible clinical benefit of the abscopal effect in the treatment of malignant melanoma.
Authors: Jeffrey S Weber; Asim Amin; David Minor; Jonathan Siegel; David Berman; Steven J O'Day Journal: Melanoma Res Date: 2011-12 Impact factor: 3.599
Authors: Anna Maria Di Giacomo; Paolo A Ascierto; Lorenzo Pilla; Mario Santinami; Pier Francesco Ferrucci; Diana Giannarelli; Antonella Marasco; Licia Rivoltini; Ester Simeone; Stefania Vl Nicoletti; Ester Fonsatti; Diego Annesi; Paola Queirolo; Alessandro Testori; Ruggero Ridolfi; Giorgio Parmiani; Michele Maio Journal: Lancet Oncol Date: 2012-08-13 Impact factor: 41.316
Authors: M Zahidunnabi Dewan; Ashley E Galloway; Noriko Kawashima; J Keith Dewyngaert; James S Babb; Silvia C Formenti; Sandra Demaria Journal: Clin Cancer Res Date: 2009-08-25 Impact factor: 12.531
Authors: Satoko Matsumura; Baomei Wang; Noriko Kawashima; Steve Braunstein; Michelle Badura; Thomas O Cameron; James S Babb; Robert J Schneider; Silvia C Formenti; Michael L Dustin; Sandra Demaria Journal: J Immunol Date: 2008-09-01 Impact factor: 5.422
Authors: Ekokobe Fonkem; Erik J Uhlmann; Scott R Floyd; Anand Mahadevan; Ekkehard Kasper; Omar Eton; Eric T Wong Journal: Expert Rev Neurother Date: 2012-10 Impact factor: 4.618
Authors: Eric D Brooks; Jonathan E Schoenhals; Chad Tang; Goran Micevic; Daniel R Gomez; Joe Y Chang; James W Welsh Journal: Cancer J Date: 2016 Jul-Aug Impact factor: 3.360